Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years - Concepedia

Concepedia

Publication | Closed Access

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years

152

Citations

20

References

2008

Year

Tino F. Schwarz, Marek Spaczyński, Achim Schneider, Jacek Wysocki, Pamela Perona, Sylviane Poncelet, Toufik Zahaf, Karin Hardt, Dominique Descamps, Gary Dubin

ImmunologyGynecologyImmunotherapyCervical Cancer PreventionHuman Papillomavirus VaccinesPublic HealthVaccine SafetyVaccine DevelopmentCervical HealthVaccine TestingVaccinationCervical Cancer ManagementCervical Cancer ScreeningCervical CancerPrecision VaccinologyVaccine EfficacyMedicineVaccine ResearchPrecancerous Lesions

References

	Year	Citations

Page 1

Page 1